Oxford Sciences Innovation

Oxford Sciences Innovation (OSI) is a prominent venture capital firm based in Oxford, UK, dedicated to transforming Oxford University's scientific research into impactful commercial ventures. Established in 2015, OSI collaborates closely with the university to identify and support spin-out companies that address significant global challenges through innovative technologies. The firm's portfolio encompasses a diverse range of sectors, including life sciences, deep tech, health tech, and software & AI, reflecting its commitment to fostering groundbreaking solutions across multiple disciplines.

OSI's investment strategy focuses on early-stage companies, providing capital and strategic guidance to accelerate their growth and development. By leveraging Oxford's extensive research capabilities, OSI aims to create and scale businesses that tackle complex issues such as rare diseases, cancer, sustainability, nuclear fusion, quantum computing, and cybersecurity. The firm's approach combines deep scientific expertise with entrepreneurial experience, facilitating the successful commercialization of university research.

With a portfolio valued at over $2 billion, OSI has been instrumental in creating more than 100 companies, generating over 1,500 new jobs, and contributing significantly to the expansion of Oxford's research and science ecosystem. The firm's impact underscores its role as a catalyst for innovation, bridging the gap between academic research and real-world applications to drive economic growth and societal benefit.